Literature DB >> 12671767

[Improvement of hemostasis in laparoscopic and open partial nephrectomy with gelatin thrombin matrix (FloSeal)].

F Richter1, M E Tüllmann, I Türk, S Deger, J Roigas, A Wille, D Schnorr.   

Abstract

Long-term follow-up studies have demonstrated that effective local tumor control and long-term tumor-free progression rates can be achieved by nephron-sparing surgery. However, hemostasis is a major issue and the lack of effective means of hemostasis has limited a wider use of the laparoscopic approach to nephron-sparing surgery. Between January 2001 and August 2002, a total of 36 patients with renal cell carcinomas were treated by partial nephrectomies using a two-component tissue sealant (FloSeal). The median age was 55.2 years (range: 34-71 years). Follow-up time was 1-18 months (median: 5.5 months). The tumor diameter ranged from 2 to 5 cm (median: 2.9 cm). Open retroperitoneal surgery was performed in 17 cases and laparoscopic partial nephrectomy in 19 cases. The two-component tissue sealant (consisting of a gelatin matrix with granular and thrombin components) was applied after resection of the tumor and before perfusion of the kidney. The following parameters were recorded: (1) time until complete hemostasis was achieved, (2) decrease in postoperative hemoglobin level, (3) postoperative bleeding, and (4) presence or absence of a perirenal hematoma 24 h and 10 days postoperatively by ultrasound. After application of the tissue sealant for 1-2 min to the moist resection site, hemostasis was immediate in all cases. During the laparoscopic partial nephrectomies, a laparoscopic applicator was used that avoided wasting the tissue sealant within the dead space of the instrument. When reperfusion of the kidney was established, hemostasis was maintained. The decrease in postoperative hemoglobin level ranged from 0.3 to 1.2 points (median: 0.8 points). None of the patients required blood transfusions. There were no cases of postoperative bleeding. An ultrasound examination 24 h and 10 days postoperatively demonstrated the absence of a significant perirenal hematoma. The two-component tissue sealant FloSeal provided immediate and durable hemostasis in open and laparoscopic partial nephrectomies. The tissue sealant may provide a tool to expand the possibilities of laparoscopic nephron-sparing surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671767     DOI: 10.1007/s00120-002-0280-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  9 in total

Review 1.  The use of fibrin sealant in urology.

Authors:  Bijan Shekarriz; Marshall L Stoller
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

2.  Laparoscopic nephron-sparing surgery for renal tumors.

Authors:  K Jeschke; R Peschel; J Wakonig; L Schellander; G Bartsch; K Henning
Journal:  Urology       Date:  2001-11       Impact factor: 2.649

3.  A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery.

Authors:  K L Renkens; T D Payner; T J Leipzig; H Feuer; M A Morone; J M Koers; K J Lawson; R Lentz; H Shuey; G L Conaway; G B Andersson; H S An; M Hickey; J F Rondinone; N S Shargill
Journal:  Spine (Phila Pa 1976)       Date:  2001-08-01       Impact factor: 3.468

4.  Fibrin glue in renal and ureteral trauma.

Authors:  H B Kram; H P Ocampo; M P Yamaguchi; R C Nathan; W C Shoemaker
Journal:  Urology       Date:  1989-03       Impact factor: 2.649

5.  Fibrin adhesives in surgery of the renal parenchyma.

Authors:  H Urlesberger; K Rauchenwald; K Henning
Journal:  Eur Urol       Date:  1979       Impact factor: 20.096

6.  Does the absorbable fibrin adhesive bandage facilitate partial nephrectomy?

Authors:  R L Cornum; A F Morey; R Harris; V Gresham; R Daniels; R W Knight; D Beall; A Pusateri; J Holcomb; M Macphee
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

7.  Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group.

Authors:  M C Oz; D M Cosgrove; B R Badduke; J D Hill; M R Flannery; R Palumbo; N Topic
Journal:  Ann Thorac Surg       Date:  2000-05       Impact factor: 4.330

8.  Laparoscopic nephron sparing surgery for small renal cell carcinoma.

Authors:  G Janetschek; P Daffner; R Peschel; G Bartsch
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

9.  FloSeal: a new hemostyptic agent in peripheral vascular surgery.

Authors:  O Reuthebuch; M L Lachat; P Vogt; U Schurr; M Turina
Journal:  Vasa       Date:  2000-08       Impact factor: 1.961

  9 in total
  1 in total

1.  The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study.

Authors:  Mario Testini; Rinaldo Marzaioli; Germana Lissidini; Agostino Lippolis; Francesco Logoluso; Angela Gurrado; Domenica Lardo; Elisabetta Poli; Giuseppe Piccinni
Journal:  Langenbecks Arch Surg       Date:  2009-05-07       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.